Ac immune reports second quarter 2022 financial results and provides corporate update

Lausanne, switzerland, july 28, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported results for the quarter ended june 30, 2022, and provided a corporate update.
ACIU Ratings Summary
ACIU Quant Ranking